AK
Koval, Alexey
Affiliation entities
Research groups
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Signalomics for molecular tumor boards and precision oncology of breast and gynecological cancers | Molecular systems biology | 2025 | 66 | 35 | |||
| Loss of the conserved switch III region in a G protein leads to severe pediatric encephalopathy | Science signaling | 2025 | 15 | 0 | |||
| Clinical-molecular profiling of atypical GNAO1 patients : Novel pathogenic variants, unusual manifestations, and severe molecular dysfunction | Genes & diseases | 2025 | 36 | 27 | |||
| Success and Controversy of Natural Products as Therapeutic Modulators of Wnt Signaling and Its Interplay with Oxidative Stress : Comprehensive Review Across Compound Classes and Experimental Systems | Antioxidants | 2025 | 43 | 277 | |||
| Syndecan-2 positively regulates Wnt/β-catenin signaling in breast cancer cells | International journal of biochemistry & cell biology | 2025 | 37 | 0 | |||
| Atypical GNAO1 variants in severe childhood speech disorders: clinical, genetic, and molecular insights | Molecular autism | 2025 | 11 | 9 | |||
| Integration of Wnt-inhibitory activity and structural novelty scoring results to uncover novel bioactive natural products : new Bicyclo[3.3.1]non-3-ene-2,9-diones from the leaves of Hymenocardia punctata | Frontiers in chemistry | 2024 | 123 | 95 | |||
| Germline mutations in a G protein identify signaling cross-talk in T cells | Science | 2024 | 183 | 0 | |||
| Neomorphic Gαo mutations gain interaction with Ric8 proteins in GNAO1 encephalopathies | The Journal of clinical investigation | 2024 | 98 | 97 | |||
| Zinc for GNAO1 encephalopathy : preclinical profiling and a clinical case | Med | 2024 | 131 | 251 | |||
| Challenging Reported Frizzled-Targeting Compounds in Selective Assays Reveals Lack of Functional Inhibition and Claimed Profiles | ACS pharmacology & translational science | 2024 | 192 | 107 | |||
| Chemical and Biological Characterization of Metabolites from Silene viridiflora Using Mass Spectrometric and Cell-Based Assays | Biomolecules | 2024 | 97 | 286 | |||
| Clinical and Molecular Profiling in GNAO1 Permits Phenotype–Genotype Correlation | Movement disorders | 2024 | 99 | 159 | |||
| GNAO1 Mutations Affecting the N‐Terminal α‐Helix of Gαo Lead to Parkinsonism | Movement disorders | 2024 | 115 | 214 | |||
| Cis-regulatory polymorphism at fiz ecdysone oxidase contributes to polygenic evolutionary response to malnutrition in Drosophila | PLOS genetics | 2024 | 72 | 147 | |||
| Clinical Cases and the Molecular Profiling of a Novel Childhood Encephalopathy-Causing GNAO1 Mutation P170R | Cells | 2023 | 111 | 64 | |||
| Wnt-Independent SARS-CoV-2 Infection in Pulmonary Epithelial Cells | Microbiology spectrum | 2023 | 186 | 154 | |||
| Shallow- and deep-water Ophiura species produce a panel of chlorin compounds with potent photodynamic anticancer activities | Antioxidants | 2023 | 242 | 77 | |||
| Clofazimine: a journey of a drug | Biomedicine & pharmacotherapy | 2023 | 97 | 296 | |||
| In-depth molecular profiling of an intronic GNAO1 mutant as the basis for personalized high-throughput drug screening | Med | 2023 | 135 | 1 | |||
| Pediatric GNAO1 encephalopathies: from molecular etiology of the disease to drug discovery | Neural Regeneration Research | 2023 | 101 | 146 | |||
| Improved approaches to channel capacity estimation discover compromised GPCR signaling in diverse cancer cells | iScience | 2023 | 92 | 62 | |||
| Gαi2-induced conductin/axin2 condensates inhibit Wnt/β-catenin signaling and suppress cancer growth | Nature communications | 2022 | 374 | 249 | |||
| Wnt-pathway inhibitors with selective activity against triple-negative breast cancer: from thienopyrimidine to quinazoline inhibitors | Frontiers in pharmacology | 2022 | 214 | 202 | |||
| Chemoenzymatic synthesis of complex phenylpropanoid derivatives by the Botrytis cinerea secretome and evaluation of their wnt inhibition activity | Frontiers in plant science | 2022 | 305 | 171 | |||
| Chemoenzymatic synthesis of original stilbene dimers possessing wnt inhibition activity in triple-negative breast cancer cells using the enzymatic secretome of Botrytis cinerea pers | Frontiers in chemistry | 2022 | 237 | 174 | |||
| Restoration of the GTPase activity and cellular interactions of Gαo mutants by Zn2+ in GNAO1 encephalopathy models | Science advances | 2022 | 204 | 180 | |||
| Mouse models characterize GNAO1 encephalopathy as a neurodevelopmental disorder leading to motor anomalies: from a severe G203R to a milder C215Y mutation | Acta neuropathologica communications | 2022 | 277 | 149 | |||
| Mining natural compounds to target WNT signaling: land and sea tales | Pharmacology of the WNT signaling system | 2021 | 221 | 1 | |||
| Pediatric encephalopathy: cinical, biochemical and cellular insights into the role of Gln52 of GNAO1 and GNAI1 for the dominant disease | Cells | 2021 | 404 | 207 | |||
| A cytotoxic porphyrin from North Pacific brittle star Ophiura sarsii | Marine Drugs | 2021 | 493 | 237 | |||
| Optimization of the clofazimine structure leads to a highly water-soluble C3-aminopyridinyl riminophenazine endowed with improved anti-Wnt and anti-cancer activity in vitro and in vivo | European Journal of Medicinal Chemistry | 2021 | 287 | 180 | |||
| Unlocking the Wnt pathway : therapeutic potential of selective targeting FZD7 in cancer | Drug discovery today | 2021 | 547 | 528 | |||
| Short stature and combined immunodeficiency associated with mutations in RGS10 | Science Signaling | 2021 | 233 | 0 | |||
| Isolation and identification of isocoumarin derivatives with specific inhibitory activity against wnt pathway and metabolome characterization of lasiodiplodia venezuelensis | Frontiers in Chemistry | 2021 | 369 | 488 | |||
| Macropinocytosis requires Gal-3 in a subset of patient-derived glioblastoma stem cells | Communications Biology | 2021 | 344 | 211 | |||
| Generation of stilbene antimicrobials against multiresistant strains of Staphylococcus aureus through biotransformation by the enzymatic secretome of Botrytis cinerea | Journal of Natural Products | 2020 | 358 | 497 | |||
| Beyond TNBC: repositioning of clofazimine against a broad range of Wnt-dependent cancers | Frontiers in Oncology | 2020 | 339 | 257 | |||
| Targeting the Wnt signalling pathway in cancer: prospects and perils | Swiss Medical Weekly | 2019 | 596 | 355 | |||
| Chemo-diversification of plant extracts using a generic bromination reaction and monitoring by metabolite profiling | ACS Combinational Science | 2019 | 406 | 0 | |||
| A high-throughput assay pipeline for specific targeting of frizzled GPCRs in cancer | Methods in Cell Biology | 2019 | 362 | 0 | |||
| Towards the first targeted therapy for triple-negative breast cancer: Repositioning of clofazimine as a chemotherapy-compatible selective Wnt pathway inhibitor | Cancer Letters | 2019 | 1,148 | 491 | |||
| Dramatic dysbalancing of the Wnt pathway in breast cancers | Scientific Reports | 2018 | 315 | 162 | |||
| High capacity in G protein-coupled receptor signaling | Nature Communications | 2018 | 390 | 208 | |||
| Tannins from Syzygium guineense suppress Wnt signaling and proliferation of Wnt-dependent tumors through a direct effect on secreted Wnts | Cancer Letters | 2018 | 337 | 737 | |||
| High-throughput targeted screening in triple-negative breast cancer cells identifies Wnt-inhibiting activities in Pacific brittle stars | Scientific Reports | 2017 | 399 | 208 | |||
| Golgi-Resident Gαo Promotes Protrusive Membrane Dynamics | Cell | 2017 | 481 | 471 | |||
| Cardamonin, a chalcone, inhibits human triple negative breast cancer cell invasiveness by downregulation of Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition | BioFactors | 2017 | 437 | 763 | |||
| Inhibition of Wnt signalling and breast tumour growth by the multi-purpose drug suramin through suppression of heterotrimeric G proteins and Wnt endocytosis | Biochemical Journal | 2016 | 404 | 453 | |||
| A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent Cancers | Cancers | 2016 | 414 | 359 |
